Todd Krueger came to AOBiome with 20+ years of experience in healthcare strategy, business development, operations and finance. He most recently led commercial efforts for the genomics platform at the Broad Institute and has held senior positions at Claritas Genomics and Life Technologies. He has also been involved in the founding of several biotech startups, including Gynesonics, Nodality, and Anestis Therapeutics. In 1999 he co-founded Fluidigm Corporation (NASDAQ: FLDM), serving as CFO and Vice President of Business Development. He also serves on the Board of Directors of several companies, including General Automation Laboratory Technologies (GALT), a microbiome tools startup. He started his career as a consultant for Bain and Company in Boston.

Mr. Krueger graduated Highest Distinction from Northwestern University with a degree in Economics and earned his MBA from the Kellogg School of Management.